Trends in antibiotic prescribing for adults in the United States—1995 to 2002

AbstractCONTEXT: The impact of national efforts to limit antibiotic prescribing has not been fully evaluated. OBJECTIVES: To analyze trends in outpatient visits associated with antibiotic prescription for U.S. adults. DESIGN: Cross-sectional study of data (1995 to 2002) from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. PARTICIPANTS: Adults ≥18 years with an outpatient visit to an office-or hospital-based medical practice or to an emergency department. All visits were classified into 1 of 4 diagnostic categories: (1) acute respiratory infection (ARI)—antibiotics rarely indicated, (2) ARI—antibiotics often indicated, (3) nonrespiratory infection—antibiotics often indicated, and (4) all others. MEASUREMENTS: Trends in: (1) Proportion of outpatient visits associated with an antibiotic prescription; (2) proportion of antibiotic prescriptions that were broad spectrum; and (3) number of visits and antibiotic prescriptions per 1,000 U.S. adults ≥18 years of age. RESULTS: From 1995–1996 to 2001–2002, the proportion of all outpatient visits that generated an antibiotic prescription decreased from 17.9% to 15.3% (adjusted odds ratio [OR] 0.84, 95% confidence interval [CI] 0.76 to 0.92). The entire reduction was because of a decrease in antibiotic prescriptions associated with visits for ARIs where antibiotics are rarely indicated from 59.9% to 49.1% (adjusted OR 0.64 95% CI 0.51 to 0.80). However, the proportion of prescribed antibiotics for these visits that were classified as broad-spectrum antibiotic prescription increased from 41.0% to 76.8%. Overall outpatient visits increased from 1693 to 1986 per 1,000 adults over the 8 years studied, but associated antibiotic prescriptions changed little, from 302 to 304 per 1,000 adults. CONCLUSION: During the study period, outpatient antibiotic prescribing for respiratory infections where antibiotics are rarely indicated has declined, while the proportion of broad-spectrum antibiotics prescribed for these diagnoses has increased significantly. This trend resulted in a 15% decline in the total proportion of outpatient visits in which antibiotics were prescribed. However, because outpatient visits increased 17% over this time period, the population burden of outpatient antibiotic prescriptions changed little.

[1]  W. Sribney,et al.  Estimates of linear combinations and hypothesis tests for survey data , 1997 .

[2]  J. Steiner,et al.  Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. , 1999, JAMA.

[3]  G. Amsden.  Pneumococcal resistance in perspective: how well are we combating it? , 2004, The Pediatric infectious disease journal.

[4]  K. Edwards,et al.  Decreased number of antibiotic prescriptions in office-based settings from 1993 to 1999 in children less than five years of age , 2002, The Pediatric infectious disease journal.

[5]  W. Schaffner,et al.  Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  V. Snow,et al.  The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part 1. , 2001, Chest.

[7]  J. Mcgowan.  Economic impact of antimicrobial resistance. , 2001, Emerging infectious diseases.

[8]  J. Steiner,et al.  Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. , 1997, JAMA.

[9]  W. Schaffner,et al.  Changes in antibiotic prescribing for children after a community-wide campaign. , 2002, JAMA.

[10]  A. Mainous,et al.  Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children. , 2003, American journal of public health.

[11]  J. Bertino.  Cost burden of viral respiratory infections: issues for formulary decision makers. , 2002, The American journal of medicine.

[12]  J. Hughes,et al.  Trends in antimicrobial drug prescribing among office-based physicians in the United States. , 1995, JAMA.

[13]  A. Anzueto,et al.  Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. , 2000, Chest.

[14]  J. Hughes,et al.  Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000 , 2003, Emerging infectious diseases.

[15]  K. O'Brien,et al.  Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. , 2004, American journal of epidemiology.

[16]  S. Sullivan,et al.  Economic Issues and Antibiotic Resistance in the Community , 2002, The Annals of pharmacotherapy.

[17]  R. Baltimore,et al.  Editorial overview: Impact of pneumococcal and influenza vaccines on otitis media , 2004, Current opinion in pediatrics.

[18]  C. Chang,et al.  Equal Effectiveness of Older Traditional Antibiotics and Newer Broad-Spectrum Antibiotics in Treating Patients with Acute Exacerbations of Chronic Bronchitis , 2003, Southern medical journal.

[19]  A. Go,et al.  Reduction in antibiotic use among US children, 1996-2000. , 2003, Pediatrics.

[20]  Ralph Gonzales,et al.  Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999 , 2003, Annals of Internal Medicine.

[21]  J. Bartlett,et al.  Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: Background☆1☆2☆3☆4☆5☆6☆7☆8 , 2001, Annals of Emergency Medicine.

[22]  Neck Surgery,et al.  Otitis media with effusion. , 2004, Pediatrics.

[23]  R. Gonzales,et al.  Principles of Appropriate Antibiotic Use for Treatment of Acute Bronchitis in Adults , 2001, Annals of Internal Medicine.

[24]  W. Schaffner,et al.  Elimination of Racial Differences in Invasive Pneumococcal Disease in Young Children After Introduction of the Conjugate Pneumococcal Vaccine , 2004, The Pediatric infectious disease journal.

[25]  R. Gonzales,et al.  Principles of Appropriate Antibiotic Use for Treatment of Nonspecific Upper Respiratory Tract Infections in Adults , 2001, Annals of Internal Medicine.

[26]  J. Bertino.  Cost burden of viral respiratory infections: Issues for formulary decision makers☆ , 2003 .

[27]  R. Platt,et al.  Reducing antibiotic use in children: a randomized trial in 12 practices. , 2001, Pediatrics.

[28]  B. Arroll,et al.  "Just say no"--reducing the use of antibiotics for colds, bronchitis and sinusitis. , 2000, The New Zealand medical journal.

[29]  R. J. Vogel,et al.  A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals. , 2003, Clinical therapeutics.

[30]  Ralph Gonzales,et al.  Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. , 2003, JAMA.

[31]  J. Bartlett,et al.  Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults: Background, Specific Aims, and Methods , 2001, Annals of Internal Medicine.

[32]  J. Bartlett,et al.  Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. , 2001, Annals of emergency medicine.

[33]  O. Cars,et al.  Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). , 1999, Scandinavian journal of infectious diseases.

[34]  B. Arroll,et al.  Antibiotics for the common cold. , 2002, The Cochrane database of systematic reviews.